Skip to main content
Funded Studies

Glenda Margaret Halliday, PhD

NHMRC Senior Leadership Fellow and Professor of Neuroscience at University of Sydney

Location: Sydney NSW Australia

Glenda Halliday, PhD, is renowned internationally for her research on neurodegeneration with a major impact on understanding disease progression. Her studies on the molecular and cellular properties of the human brain have provided core neuroanatomical and biochemical information to understand the effect of neurodegenerative diseases. After developing rigorous quantitative methods for evaluating pathology in patients with defined clinical symptoms, she revealed more extensive neurodegeneration in Parkinson's disease and related syndromes than previously thought. Comparing the brains of humans and animals, she identified differences in the functional anatomy of the main regions modulating cortical activity that are involved in neurodegenerative diseases. She has defined the earliest biochemical signatures in the brains of patients with Parkinson’s disease, dementia with Lewy bodies, and frontotemporal dementias. Her research has identified previously unrecognized brain regions that degenerate selectively in these diseases and revealed the involvement of the glial cells surrounding the neurons.


Associated Grants

  • Activity and Connectivity Drive Neuronal Vulnerability and Disease Progression in Parkinson’s Disease

    2021


  • Dual Role of Neural Activity in Parkinson’s Disease

    2021


  • In Vivo Approach to Elucidate the Pathobiology of Parkinson’s-associated Genes Using Human Diseased Neurons

    2020


  • Exploring Proteins associated with Alpha-synuclein in Astrocytes at Different Stages of Parkinson’s Disease

    2019


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.